Jane Street
KRSA

Jane Street’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Jane Street’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,909
Closed -$55.1K – 8747
2023
Q2 		$55.1K Buy
+1,909
New +$9.89K ﹤0.01% 8188
2023
Q1 		– Sell
-182
Closed -$16.7K – 9171
2022
Q4 		$16.7K Buy
+182
New +$2.15K ﹤0.01% 8647
2022
Q3 		– Sell
-416
Closed -$32K – 9812
2022
Q2 		$32K Buy
+416
New +$5.96K ﹤0.01% 9038
2021
Q4 		– Sell
-119
Closed -$51K – 10167
2021
Q3 		$51K Buy
+119
New +$7.79K ﹤0.01% 9540

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Jane Street's KRSA Position: Q3 2023 in Review

Jane Street sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q3 2023, closing a stake of 1,909 shares — an estimated $55.1K sold.

Jane Street first reported a position in KRSA in Q3 2021 and held it in 4 quarters. The position peaked at $55.1K in Q2 2023. 15 funds tracked by Wall St. Rank hold KRSA as of Q3 2023.

  • Jane Street reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Jane Street sold 1,909 Korsana Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $55.1K.
  • Jane Street first reported a position in Korsana Biosciences, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • Jane Street's Korsana Biosciences, Inc. Common Stock position peaked at $55.1K in Q2 2023.
  • 15 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.